JAB SEC filings, in plain English
Everything JAB Acquisition I has filed with the SEC that we hold — 32 filings, newest first, 29 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: SEC Form 8-K Current Report (routine compliance exhibit) disclosing a trademark settlement agreement and voluntary trading symbol/corporate name transition. First, regarding mechanics: according to the Company, as filed under signature of Chief Executive Officer Joshua Jagid on August 21, 2026, the arrangement does not affect the validity of outstanding stock certificates, existing shareholders’ ownership percentages, the underlying capital structure, or the registrant’s CIK. The 2027-06-11 redemption deadline and $10.02 trust value per share remain unchanged. Second, regarding substance: the Company states it executed a settlement with an undisclosed Claimant to amicably resolve an outstanding trademark dispute over the firm’s name and trading symbol. Under those stated terms, the Company filed a request with Nasdaq to voluntarily replace the JABRU, JAB, JABRW, and JABRR symbols with ATLQ, ATLQU, ATLQW, and ATLQR effective upon exchange confirmation. The Company further intends to adopt the name Atlantic Acquisition Corp I, subject to formal board of directors and shareholder approval. No target acquisition, financing event, or sponsor conduct shift is reported. Why it matters: By resolving a branding-related legal exposure through settlement, the Company removes litigation distraction during the search phase without touching shareholder economics or the combination mandate. Public holders retain full access to the $10.02 trust per share and the 2027-06-11 redemption horizon, with no voting or redemption action triggered at this stage. The administrative ticker update and subsequent name change reflect routine corporate housekeeping rather than deal progression or sponsor capitulation, preserving the status quo until a business target is identified.
What changed: A Schedule 13G/A, formally titled a ‘beneficial ownership report’ (Reference No. [0001193125-26-352529]), filed by five affiliated investment entities. The filing identifies Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, and Sculptor Capital Management, Inc. as reporting persons. Because the provided text contains only entity names and omits standard 13G/A disclosure blocks (aggregate shares, percentage of class, or acquisition dates), the document does not specify a quantifiable shift in position. Accordingly, it does not alter the 2027-06-11 search deadline, the $10.02 per share trust balance, any extension proposals, or the sponsor’s deal-progression timeline. Why it matters: According to the filing, the named vehicles continue to hold a reportable interest in the SPAC. Per standard regulatory practice, an amended Schedule 13G registers threshold crossings, accumulated block trades, or revisions to the purpose behind the holding between annual January deadlines. For investors tracking redemption calendars and trust preservation in a SEARCHING-phase SPAC, this confirms that a sophisticated institutional allocator is maintaining formal visibility over JAB Acquisition I. Subsequent amendments, combined proxy solicitations, or tender offers should be monitored, as coordinated positioning by significant holders often precedes mass redemption events or voting campaigns ahead of the final business combination deadline.
What changed: Quarterly report (Form 10-Q) for the period ended June 30, 2026, filed by JAB Acquisition Corp I, a blank-check company that completed its IPO on June 11, 2026. This is the first quarterly report since the IPO. The trust account held $172,816,825 as of June 30, 2026, representing $10.02 per public share (17,250,000 shares). No business combination has been announced. The company has until June 11, 2027 (the Combination Period) to complete a deal, with the option to extend for up to two additional three-month periods by depositing $0.10 per share each time. No extension has been made. The sponsor has agreed to standard lock-up and waiver of redemption rights. Management has identified substantial doubt about the company's ability to continue as a going concern if a business combination is not completed within the Combination Period. No changes to redemption mechanics, trust value, or sponsor conduct beyond the initial IPO terms. Why it matters: This filing confirms the SPAC is in its early search phase with no target identified. The trust value per share is $10.02, slightly above the $10.00 IPO price due to interest earned. Investors should note the ticking clock: the company has 12 months from the IPO date (June 11, 2026) to complete a deal. The going concern disclosure signals that failure to find a target could lead to liquidation. No material adverse changes or sponsor red flags.
trust account, redeemable shares, going-concern doubt +2nothing moved · 5 with no prior record of ours
- Trust account
- not previously extracted$172.8M
- Redeemable shares
- not previously extracted17.3M
- Going-concern doubt
- stated · unchanged
- Sponsor loans outstanding
- $49Knot matched in this filing
- Mandate language
- focus our search on high potential businesses based in the U… · unchanged
The clause “June 30, 2026. Cash Held in Trust Account As of June 30, 2026, the Company had $ 172,816,825 in cash held in the Trust Account, which consisted of interest-earning demand deposits. 8 JAB ACQUISITION CORP I Notes to Unaudited Financial”…
The clause …“and contingencies (Note 6) Class A ordinary shares, $0.0001 par value; 17,250,000 shares subject to possible redemption as of June 30, 2026 at $10.02 per share 172,816,825 Shareholders’ Equity: Preference shares, $ 0.0001 par”…
The clause …“of a Business Combination. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: A Schedule 13G beneficial ownership report filed by Highbridge Capital Management, LLC. Per the excerpt, Highbridge Capital Management, LLC submitted a Schedule 13G to disclose beneficial ownership interests. Regarding SPAC mechanics, the text contains no share quantities, percentage thresholds, acquisition dates, or comparative historical positions to demonstrate a change in holding size; it does not reference the $10.02 trust per share, the 2027-06-11 deadline, redemption pacing, extension triggers, or target acquisition progress. With respect to other substance, the document includes no claims regarding customer contracts, revenue streams, market size, strategic initiatives, technology roadmaps, commercial partnerships, litigation posture, or personnel appointments attributed to Highbridge Capital Management, LLC or the sponsor. Why it matters: Schedule 13G filings satisfy regulatory transparency mandates for institutional investors crossing statutory ownership thresholds. Because the provided excerpt omits numerical position data, transactional timelines, or strategic commentary from Highbridge Capital Management, LLC, it does not alter investor modeling around redemption windows, trust value preservation, liquidation horizons, or merger development schedules. Market participants tracking extension votes, negotiation catalysts, or sponsor conduct will require the complete filing or subsequent amendment schedules to identify concrete capital allocation signals or governance implications for JAB Acquisition I.
What changed: Beneficial ownership report under Schedule 13G, labeled by the filer as a regulatory disclosure of equity holdings. The excerpt identifies Aristeia Capital, L.L.C. as the reporting entity. It contains no share counts, percentages, transaction dates, or purpose statements. It discloses nothing regarding redemption deadlines, trust value, extension procedures, business combination status, or sponsor conduct. Why it matters: Schedule 13G filings monitor passive stake accumulation. This segment offers no operational, financial, or strategic commentary. The filer advances no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Investors cannot derive liquidity timing, redemption pressure, or valuation adjustments from this text.
What changed: A Joint Filing Agreement (Exhibit 99.1) accompanying a Schedule 13G, wherein Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, and David J. Snyderman agree to submit a single SEC statement on behalf of all four parties pursuant to Rule 13d-1(k) of the Securities Exchange Act of 1934. This routine compliance exhibit introduces no changes to JAB Acquisition Corp I’s mechanics. It formally links four affiliated entities and individuals into one reporting bloc for their beneficial ownership positions as of June 30, 2026, with Hayley Stein designated as the attorney-in-fact to execute the filings on August 13, 2026. No adjustments to the redemption window, trust accounting, extension mechanisms, target search timeline, or sponsor governance are disclosed or triggered by this text. Why it matters: For investors monitoring the redemption calendar and trust trajectory, this document provides zero procedural leverage—it does not amend the applicable liquidation deadline, nor does it touch per-share trust balances or warrant exercise structures referenced in tracking dashboards. Its utility lies in portfolio transparency: it clarifies that Magnetar-network participants are consolidating their Section 13(d) reporting rather than acting independently, meaning any future aggregate stake disclosures, market activity, or board nominations will reflect the combined position of all four signatories. As a purely administrative boilerplate governing how ownership data is presented to the SEC, it does not signal deal acceleration, capital deployment, or shareholder rights shifts.
What changed: Schedule 13G beneficial ownership report, classified as a routine compliance exhibit. The filing identifies Decagon Asset Management LLP and Benjamin John Durham as current beneficial owners of JAB common stock. It introduces no changes to the reported $10.02 trust per share, the 2027-06-11 redemption deadline, any extension proposals, target deal progress, or sponsor conduct. Why it matters: Because the document solely registers existing equity positions without invoking corporate events, trust adjustments, or timeline shifts, it leaves all investor-tracking mechanics—redemption windows, trust account performance, acquisition momentum, and sponsor behavior—completely unaltered. The filing contains no operational claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel.
What changed: A routine compliance exhibit—a Limited Power of Attorney attached as Exhibit A to a Schedule 13G filing—whereby Mizuho Financial Group, Inc., Mizuho Bank, Ltd., Mizuho Americas LLC, and Mizuho Securities USA LLC authorize Takahiro Katsura to execute Form 13G submissions on their behalf. According to the filing’s text, signed executives Shuji Matsuura and Adam Hopkins delegated SEC signatory authority for routine exchange act reporting. The document reports no adjustments to JAB Acquisition I’s redemption window, trust balance mechanics, extension timeline, target deal progress, or sponsor conduct. Why it matters: Attested solely by Mizuho’s corporate governance officers, this administrative proxy carries no commercial, strategic, or structural impact on the SPAC. It discloses no customer concentrations, revenue streams, market sizing claims, technology deployments, partnership frameworks, litigation exposures, or personnel transitions that would influence investor calculus on redemptions, trust preservation, or acquisition approval.
What changed: A Joint Filing Agreement. The document does not modify redemption deadlines, trust value per share, extension procedures, business combination status, or sponsor conduct. Feis Equities LLC and Lawrence M. Feis execute this routine compliance exhibit to jointly file a Schedule 13G statement and any subsequent Schedule 13D amendments concerning Class A ordinary shares of JAB Acquisition Corp I, referencing a previously submitted statement dated August 7, 2026. Why it matters: It consolidates future regulatory disclosure responsibilities for the two signatories into a single filer pathway under Rule 13d-1(k), affecting how the Commission tracks their combined or separate beneficial ownership. The filing introduces no operational shifts to the trust account, public offering mechanics, or target acquisition timeline, and contains no substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel.
What changed: A Form 8-K current report and accompanying press release. JAB Acquisition Corp I announced that holders of the 17,250,000 units sold in the IPO may elect to separately trade the Class A ordinary shares, rights, and warrants commencing August 5, 2026. The filing notes that each unit contains one Class A ordinary share, one right to receive one-fourth (1/4) of a share, and one redeemable warrant exercisable at $11.50 per share. Separated components will trade under symbols JAB, JABRR, and JABRW, while unseparated units remain JABRU. Execution requires brokers to contact transfer agent Continental Stock Transfer & Trust Company, yielding no fractional warrants, rights, or shares. Why it matters: This routine mechanical milestone expands liquidity options for public shareholders by unbundling the unit structure into tradable equity and derivative instruments without altering the entity's incorporation jurisdiction, reporting status, or deal search trajectory. The document additionally identifies D. Boral Capital LLC as the sole book-running manager, confirms the Form S-1 registration statement was declared effective on June 9, 2026, and attributes the announcement to Chairman and Chief Executive Officer Joshua Jagid.
What changed: Quarterly report on Form 10-Q for the period ended March 31, 2026, filed by JAB Acquisition Corp I, a blank-check company still searching for a business combination target. This is JAB Acquisition Corp I’s first 10-Q since its IPO on June 11, 2026. The report covers only the pre-IPO stub period from inception (March 10, 2026) through March 31, 2026, so it contains no trust-account activity, no redemption activity, and no deal announcement. The IPO and private placement (17,250,000 units at $10.00, plus 260,000 private units — total gross proceeds of $175,100,000) are reported as subsequent events. Key financials as of March 31: $50,230 in prepaid expenses, $48,895 in related-party promissory note, $1,335 in shareholders’ equity (deficit from $23,665 in formation costs). As of the filing date (July 23, 2026), 18,345,000 Class A shares and 9,857,143 Class B shares outstanding. Management discloses a material weakness in internal controls (lack of segregation of duties, limited personnel). The sponsor’s promissory note was repaid at IPO. The SPAC has until June 11, 2027 to complete a deal, with two possible three-month extensions at $0.10 per share each. No target identified or letter of intent announced. Why it matters: This filing is the foundational baseline for JAB Acquisition Corp I. It confirms the trust structure (initial $10.00 per share), the sponsor’s founder shares (9,857,143 Class B shares, representing ~35% of post-IPO shares, none forfeited), and the warrant/right terms (each Unit: one share, one warrant at $11.50, one right to receive 1/4 share at deal). It also documents that the sponsor purchased 260,000 private units ($2.6 million) alongside the IPO, and that the sponsor held $811,381 of IPO proceeds outside trust (now transferred). The going-concern disclosure is standard for pre-deal SPACs. There is no litigation, no redemption demand data, and no change in trust value beyond the initial $10.00. The filing is otherwise a routine compliance exhibit that provides no new forward-looking deal information.
What changed: A Joint Filing Agreement (Exhibit 99.2), which operates as a routine compliance exhibit authorizing coordinated submission of a single Statement on Schedule 13G regarding Class A ordinary shares of JAB Acquisition I Corp. Per the agreement dated June 17, 2026, Feis Equities LLC and Lawrence M. Feis stipulated that they will file their Schedule 13G statement on behalf of each other pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934, expressly covering any future amendments including Schedule 13D filings. This administrative coordination does not modify redemption windows, trust share balances, extension triggers, business combination milestones, or sponsor governance directives. Why it matters: Because Feis Equities LLC and Lawrence M. Feis explicitly restricted the document to regulatory filing logistics, it contains no substantive claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. For investors tracking capital structure and timeline mechanics, the agreement confirms shared beneficial ownership reporting duties without altering voting power, conversion rights, or the operational cadence required to resolve the SEARCHING stage.
What changed: A Form 8-K Current Report (Items 8.01 and 9.01) filed on June 17, 2026, which formally announces the consummation of JAB Acquisition Corp I’s initial public offering on June 11, 2026, and includes the inaugural audited balance sheet, a PCAOB audit report, and comprehensive notes to the financial statements rather than a merger agreement, resignation, interview transcript, routine compliance exhibit, investor presentation, or lawsuit. Per the Company’s disclosures, the IPO closed on June 11, 2026, with the issuance and sale of 17,250,000 Units (including 2,250,000 Units from the fully exercised over-allotment option) at $10.00 per Unit, yielding gross proceeds of $172,500,000. Simultaneously, management states the Company completed a private placement of 260,000 Private Units to JAB Acquisition Sponsor I, LLC at $10.00 per Unit for $2,600,000. The filing confirms that $10.00 per Unit sold, inclusive of private placement proceeds, is deposited into a Trust Account, with the audited balance sheet reflecting exactly $172,500,000 in Cash held in Trust Account as of June 11, 2026. The documentation establishes a strict 12-month Combination Period ending June 11, 2027, with management noting the Board may extend this window for up to two additional three-month periods by mandatorily depositing $0.010 per share into the Trust Fund for each period. Should no Business Combination occur within this timeframe, the Company states there will be a mandatory liquidation, triggering a cash redemption of 100% of Public Shares calculated using the exact aggregate Trust Account balance divided by outstanding Public Shares, net of Permitted Withdrawals capped at $100,000 for dissolution expenses. The Sponsor waives all redemption rights to Founder Shares and Public Shares, and has agreed to indemnify the Trust Account against third-party claims to preserve funds at the lesser of $10.00 per Public Share or the actual per-share trust balance, though management expressly notes it cannot verify the Sponsor’s capacity to fulfill these indemnities. Each Unit carries one Redeemable Warrant exercisable at $11.50 per share and one Right granting entitlement to one-fourth of a Class A Ordinary Share post-combination, with 17,510,000 total warrants outstanding as of closing. Regarding other substance, management states the Company’s business plan targets high potential U.S.-based businesses and explicitly discloses that zero operating revenues will be generated until an initial Business Combination closes. As of the reporting date, the Company had commenced no operations, incurred transaction costs totaling $3,396,791 (breakdown: $1,000,000 underwriter fees, $1,240,000 fair value of representative shares, $1,156,791 other offering costs), and distributed 95,000 Class A Ordinary Shares to three independent directors valued by management at $117,800, subject to lock-up provisions deferring expense recognition until a Business Combination is deemed probable. MaloneBailey, LLP (PCAOB ID#206) independently reports that these operational uncertainties and the fixed liquidation deadline raise substantial doubt about the Company’s ability to continue as a going concern. Why it matters: This filing permanently anchors the redemption pool at $172,500,000, establishing the definitive base metric for per-share payout calculations and eliminating pre-IPO settlement ambiguities. The codified 12-month deadline coupled with the transparent $0.010 per share extension mechanic forces investors to model the exact capital dilution impact of any future vote-to-extend against the probability of a announced target. The sponsor’s explicit redemption waivers, combined with the unconditional $10,000 monthly administrative fee and available Working Capital Loan conversion pathway, structurally align sponsor economics with long-term value creation while ring-fencing public capital from operational burn during the discovery phase. Finally, the auditor’s unqualified opinion paired with the mandatory Going Concern disclaimer legally quantifies the binary risk profile, compelling tracked investors to monitor extension trigger events, trust interest accrual rates, and target confidentiality filings as primary valuation drivers ahead of the June 11, 2027 liquidation horizon.
What changed: SEC Schedule 13G beneficial ownership report listing affiliated reporting entities. The filing registers five affiliated entities—Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, and Sculptor Capital Management, Inc.—as jointly reporting their beneficial ownership stake in JAB Acquisition I common stock. The text provides no updates to the June 11, 2027 redemption deadline, the $10.02 per share trust balance, extension procedures, business combination search activity, or sponsor management conduct. Why it matters: While the exhibit contains no operational disclosures, financial projections, or strategic commentary, the explicit aggregation of holdings across multiple Sculptor Capital vehicles clarifies how voting and investment power is legally structured. For investors tracking redemption calendars and potential large-holder behavior ahead of a future merger vote, this disclosure signals coordinated institutional positioning rather than dispersed retail or passive flows. The filing itself advances no claims about target sectors, market size, partnership pipelines, litigation exposure, or personnel appointments; any strategic direction remains entirely attributable to the sponsor, not to the reporting holders.
What changed: Current Report on Form 8-K announcing the closing of the initial public offering (IPO) of JAB Acquisition Corp I, including the full exercise of the underwriters' over-allotment option, and the entry into various definitive agreements (underwriting, trust, warrant, rights, letter, private placement, registration rights, indemnity, administrative services). This 8-K reports the consummation of the IPO on June 11, 2026, with the sale of 17,250,000 units at $10.00 per unit (including the over-allotment), generating gross proceeds of $172,500,000, all of which was deposited into the trust account. The SPAC also completed a private placement of 260,000 units to the sponsor for $2,600,000. The amended and restated memorandum and articles of association were adopted, and three independent directors (Luisa Ingargiola, Kyle Miller, David Pfeffer) were appointed. The trust per share is $10.00. The deadline to complete a business combination is 12 months from closing (June 11, 2027), subject to two possible 3-month extensions by the sponsor. Sponsor and insiders agreed to lock-up, vote in favor of a business combination, and waive redemption rights on founder shares and private placement securities. Why it matters: This filing establishes the SPAC's capital structure, trust value, and deadline for a business combination. Investors need to track the trust per share ($10.00), the deadline (initially June 11, 2027), and the terms of sponsor/insider commitments. It confirms the SPAC is now public and searching for a target. No business combination target is identified, and no deal terms are provided.
What changed: This document is a Schedule 13D, formally classified by the SEC as a beneficial ownership report filed to disclose when a person or group acquires, directly or indirectly, more than five percent of a registered class of equity securities. The provided filing text consists solely of the form designation and an accession number, followed by a system note stating the structured holder table is absent. Accordingly, no alterations are reported regarding JAB Acquisition I’s redemption deadline, trust share composition, extension vote procedures, merger target advancement, or sponsor governance conduct. Why it matters: A Schedule 13D signals a shift in significant equity stakes that can influence voting power ahead of a business combination, trigger proxy solicitation windows, or indicate activist accumulation preceding de-SPAC execution. Because the beneficial owner’s identity, share count, and transaction history are missing from this truncated extract, no claims regarding customers, revenue, market sizing, operational strategy, technology pipelines, partnership arrangements, pending litigation, or executive appointments can be sourced or verified. Investors should monitor for the complete exhibit package to assess whether the filing carries material implications for liquidity expectations or control dynamics ahead of the scheduled redemption horizon.(flagged for human review)
What changed: SEC Form 3 – Initial Statement of Beneficial Ownership, a routine compliance exhibit reporting insider equity positions. According to the filing submitted by JAB Acquisition Sponsor I, LLC, the document explicitly states 'No non-derivative transactions or holdings reported,' meaning the reporting person’s 10% ownership stake remained entirely static through the 2026-06-10 filing date. Why it matters: For investors monitoring the 2027-06-11 deadline, $10.02 trust/share amount, and SEARCHING operational status, this zero-transaction report confirms the sponsor neither augmented nor diluted its promoter interest during the reporting window. The filing contains no statements, data, or commitments regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. While procedurally routine, the confirmed static holding profile eliminates ambiguity around off-market share movements that could otherwise signal pre-announcement liquidity pressures, redemption hedging, or shifting sponsor conviction ahead of any business combination pursuit.
What changed: 424B4 prospectus for initial public offering of JAB Acquisition Corp I, a newly formed blank check company. This is the initial public offering prospectus. JAB Acquisition Corp I was formed on March 10, 2026. It is offering 15,000,000 units at $10.00 per unit, each unit consisting of one Class A ordinary share, one redeemable warrant, and one right to receive one-fourth of one Class A ordinary share upon a business combination. The trust will hold $150,000,000 ($10.00 per public share). It has 12 months from closing (June 11, 2026) to complete a business combination, with up to two 3-month extensions by depositing $0.10 per share per extension. No target has been selected. The sponsor purchased 9,857,143 founder shares for $25,000 and will purchase 260,000 private units for $2,600,000. Why it matters: Investors now have the full terms of the SPAC: trust per share $10.00, deadline June 11, 2027 (with possible extensions to December 2027), redemption rights, warrant and right structure, sponsor incentives, and dilution details. This is the baseline for all future decisions on redemptions, extensions, and deal evaluation.
What changed: This document is a SEC Form 3, an insider ownership report filed for JAB Acquisition Corp I. The filing discloses that Director and Chief Executive Officer Jagid Joshua has no non-derivative transactions or holdings reported. It contains no data or commentary affecting redemption deadlines, trust value per share, extension conditions, acquisition deal progress, or sponsor conduct. Why it matters: As a routine compliance exhibit, the filing makes no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Its only effect is to establish a zero-baseline for the CEO/director’s initial equity position, which matters for tracking sponsor alignment and insider trading patterns ahead of any potential business combination before the June 11, 2027 search deadline.
What changed: A Form 8-A filing submitted by JAB Acquisition Corp I to register specific classes of securities—Units, Class A Ordinary Shares, Rights, and Redeemable Warrants—for listing on The Nasdaq Stock Market LLC pursuant to Section 12(b) of the Securities Exchange Act of 1934. The registrant updated its exchange registration record to formally list the aforementioned securities. The filing specifies a par value of $0.0001 per Ordinary Share and establishes the warrant exercise price at $11.50 per share. It incorporates by reference the complete security description from the Registration Statement on Form S-1 initially filed May 19, 2026 (Registration No. 333-296035), noting that any subsequent prospectus supplements will also be deemed incorporated. The document was executed by Chief Executive Officer and Director Joshua Jagid on June 9, 2026. It reports no modifications to trust distribution mechanics, redemption pricing, shareholder vote requirements, search period extensions, or any pending business combination transactions. Why it matters: This is a routine administrative submission that finalizes the listing authorization for the company’s standardized post-IPO capital structure. It confirms that the warrant strike, unit composition, and equity definitions remain unchanged from the original S-1 prospectus. For investors tracking redemption deadlines, trust preservation, or extension triggers, the filing introduces no new contractual language or procedural shifts. The registrant makes no claims regarding customer metrics, revenue performance, market opportunity, technological advantages, strategic alliances, or ongoing litigation; operational or financial disclosures must therefore continue to rely entirely on the previously filed prospectus and periodic reports.
What changed: Form 3 — insider ownership report. According to the submitted Form 3, reporting person Jack Bressman (identified as director, CFO, COO and Secretary of JAB Acquisition Corp I) executed no non-derivative transactions and reported no changes to his holdings. The filing contains no mechanical updates to redemption parameters, trust account administration, or the business combination schedule. Why it matters: The document confirms a period of zero insider equity movement by a senior officer. As the filing explicitly states no holdings were reported, it offers no actionable data on promoter confidence, anchor investor behavior, or expected redemption rates. The filing serves solely as a procedural compliance record that leaves existing alignment metrics static pending subsequent disclosures.
What changed: FORM 3 — insider ownership report [0001213900-26-066978]. Director Ingargiola Luisa’s reported beneficial ownership position stands at 35,000 direct shares of JAB Acquisition Corp I. The filing does not detail a specific transaction date, price, or subsequent sale. Redemption mechanics, trust value calculations, and sponsor governance remain unaltered by this standard disclosure. Why it matters: As a routine regulatory snapshot, this report confirms current insider allocation but offers no forward-looking indicators on deal progress, target searches, or shareholder rights. Because it isolates a static holding of 35,000 shares without accompanying purchase/sale activity or board resolutions, it does not shift investor expectations regarding redemption windows, liquidity events, or management incentives. Any substantive claims about market strategy, customer traction, or technological pipelines are entirely absent from this filing, leaving the SPAC’s search phase unchanged in practice despite the updated filing timestamp.
What changed: SEC Form 3 initial statement of beneficial ownership filed by a director. The filing discloses that Director Miller Kyle holds 30,000 shares directly. Why it matters: According to the Form 3 filing, this routine insider disclosure confirms director-level shareholding aligned with standard SPAC capitalization. It contains no updates to the redemption deadline (2027-06-11), trust value ($10.02 per share), merger negotiations, or extension mechanisms. Shareholder rights and capitalization remain unchanged by this submission.
What changed: A Form 3 initial statement of beneficial ownership filed with the SEC by JAB Acquisition Corp I director David Pfeffer. Per the filed Form 3, Director David Pfeffer reports an initial holding of 30,000 shares acquired directly. This submission leaves the SPAC’s stated trust value per share of $10.02, its hard liquidation deadline of 2027-06-11, and its SEARCHING designation entirely unaltered. No extension motions, redemption tally updates, business combination milestones, or sponsor conduct allegations are recorded in this excerpt. Why it matters: Initial Form 3 filings provide the foundational record for insider positioning before any secondary market transactions commence. Investors tracking JAB can use this disclosed 30,000-share direct stake as a baseline to measure subsequent accumulation or distribution patterns ahead of any target declaration or deadline management. While the filing does not trigger mechanical changes to shareholder redemption windows or trust account distributions, it establishes transparency regarding director skin-in-the-game at a critical pre-deal phase. Future Forms 4 reports will determine whether Pfeffer scales this position, but this submission alone confirms the existence and size of the initial allocation without imposing new obligations or altering existing financial timelines.
What changed: Amendment No. 2 to a Registration Statement on Form S-1 (preliminary prospectus) for the initial public offering of JAB Acquisition Corp I, a blank-check company. This is the second amendment to the S-1 registration statement, updating the preliminary prospectus with current financial statements (as of March 24, 2026), revised risk factors, and expanded disclosures on the sponsor, conflicts of interest, and the terms of the offering. The document does not explicitly list changes from the prior amendment, but it reflects the ongoing process of registering the SPAC IPO. Why it matters: The filing provides the most current and complete picture of the SPAC's terms, including the trust structure, redemption mechanics, extension provisions, sponsor compensation, and risk factors. It is the document that will be used to market the IPO to investors and is essential for understanding the potential risks and mechanics of the investment.
What changed: Amendment No. 3 to Form S-1 Registration Statement for JAB Acquisition Corp I, a blank check company (SPAC) conducting its initial public offering. This is an amendment to the registration statement. Key changes include updating the unit composition to one Class A ordinary share, one redeemable warrant, and one right to receive one-fourth of a Class A ordinary share; extending the business combination period to allow up to two three-month extensions; and capping the deferred underwriting commission at $500,000. Why it matters: This filing provides complete terms for a new SPAC IPO: 15,000,000 units at $10.00 per unit with a trust of $150,000,000 ($10.02/share). Sponsor has 12 months to find a deal, extendable up to 18 months with $0.10/share deposits. Public shareholders have redemption rights. Sponsor paid $0.002/share for founder shares, indicating potential dilution. The filing outlines target focus on technology, healthcare, and logistics, with enterprise value target of $150 million or greater.
What changed: Amendment No. 1 to Form S-1 Registration Statement, a routine regulatory filing to register securities for an initial public offering of a blank check company (SPAC). The document is the revised prospectus for JAB Acquisition Corp I's IPO of 15,000,000 units at $10.00 per unit. This is the first amendment to the S-1; changes from the initial filing are not explicitly detailed in this document, but the filing clarifies the unit composition (one Class A ordinary share + one warrant + one right), finalizes the trust value per share at approximately $10.02 (stated as $10.00 per unit in the trust), confirms the deadline of June 11, 2027 (12 months from closing), and adds disclosure regarding sponsor and director compensation and conflicts. The trust value per share is $10.02 as stated in the header; the document confirms that $150,000,000 will be deposited into the trust account, resulting in a value of $10.00 per public share before interest. The deadline is 12 months from closing, and the SPAC can extend by two three-month periods with a $0.10 per share deposit each time. Why it matters: The filing discloses no pending business combination target and no substantive discussions have been initiated. It details substantial sponsor compensation (founder shares purchased at $0.002 per share, representing significant dilution for public shareholders) and a structure that permits the sponsor and directors to vote in favor of any business combination regardless of public shareholder preference. It also discloses that only Class B shareholders have the right to appoint/remove directors before the business combination, making the company a controlled company. The filing contains all standard SPAC mechanics: redemption rights, trust mechanics, and the deadline structure. For redemption calendar purposes, the trust value is $10.02 per share, and the deadline is June 11, 2027.
What changed: Form S-1 registration statement for a Special Purpose Acquisition Company (SPAC) to register its initial public offering of 15,000,000 units, each unit consisting of one Class A ordinary share, one redeemable warrant, and one right. This is a preliminary prospectus subject to completion. This is an initial S-1 filing for a new SPAC. The document establishes the proposed IPO terms: 15 million units at $10.00/unit, a 12-month business combination deadline extendable by two 3-month periods with $0.10/share deposits, a $150 million trust, a 15% share redemption cap if seeking shareholder approval, and a sponsor promote structure targeting 35% ownership post-offering via 9.86 million founder shares (purchased for $25,000) plus 260,000 private units ($2.6 million). The trust per-share value is $10.02. Why it matters: This filing is the foundational IPO document for JAB Acquisition Corp I. It establishes all key SPAC mechanics for investors: the redemption process (tender offer or shareholder vote), the $10.00 trust value, extension terms, sponsor economics ($0.002/share cost vs. $10.00 public price), and the stated acquisition focus on technology, healthcare, and logistics businesses with enterprise values of $150 million or greater. The 35% founder stake and nominal sponsor cost signal significant potential dilution for public shareholders upon a business combination.
What changed: Draft registration statement on Form S-1 (DRS) for JAB Acquisition Corp I's initial public offering, confidentially submitted to the SEC on April 20, 2026. This is the initial confidential filing of JAB Acquisition Corp I's IPO registration statement. The SPAC is newly incorporated (March 10, 2026) and is seeking to raise $200 million (20 million units at $10.00/unit). The document establishes the standard blank-check structure: each unit consists of one Class A ordinary share and one-half warrant, with an 18-month completion window extendable by sponsor deposit of $0.033/share/month. The sponsor invested $25,000 for 9,857,143 founder shares and will purchase 260,000 private units at $10.00 each. Trust proceeds are $10.00/share. No target has been selected. Why it matters: As the first public registration filing, this document establishes all structural terms for the JAB SPAC: the 18-month deadline (through late 2027), trust value of $10.00 per unit, redemption mechanics with a 15% cap in connection with shareholder votes, and sponsor economics (founder shares at ~$0.002/share). The registration remains confidential and inactive until publicly filed and declared effective, meaning no redemption dynamics are yet active.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.